These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 29879903)

  • 1. The whole transcriptome effects of the PPARα agonist fenofibrate on livers of hepatocyte humanized mice.
    de la Rosa Rodriguez MA; Sugahara G; Hooiveld GJEJ; Ishida Y; Tateno C; Kersten S
    BMC Genomics; 2018 Jun; 19(1):443. PubMed ID: 29879903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-α.
    Tateno C; Yamamoto T; Utoh R; Yamasaki C; Ishida Y; Myoken Y; Oofusa K; Okada M; Tsutsui N; Yoshizato K
    Toxicol Pathol; 2015 Feb; 43(2):233-48. PubMed ID: 25107573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of PPARα activation on whole genome gene expression in human precision cut liver slices.
    Janssen AW; Betzel B; Stoopen G; Berends FJ; Janssen IM; Peijnenburg AA; Kersten S
    BMC Genomics; 2015 Oct; 16():760. PubMed ID: 26449539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver.
    Raza-Iqbal S; Tanaka T; Anai M; Inagaki T; Matsumura Y; Ikeda K; Taguchi A; Gonzalez FJ; Sakai J; Kodama T
    J Atheroscler Thromb; 2015 Aug; 22(8):754-72. PubMed ID: 26040752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma mannose-binding lectin is stimulated by PPARα in humans.
    Rakhshandehroo M; Stienstra R; de Wit NJ; Bragt MC; Haluzik M; Mensink RP; Müller M; Kersten S
    Am J Physiol Endocrinol Metab; 2012 Mar; 302(5):E595-602. PubMed ID: 22215653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
    Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human.
    Rakhshandehroo M; Hooiveld G; Müller M; Kersten S
    PLoS One; 2009 Aug; 4(8):e6796. PubMed ID: 19710929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to perfluorooctane sulfonate or fenofibrate causes PPAR-alpha dependent transcriptional responses in chicken embryo hepatocytes.
    Cwinn MA; Jones SP; Kennedy SW
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Aug; 148(2):165-71. PubMed ID: 18565798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver.
    Yamada T; Okuda Y; Kushida M; Sumida K; Takeuchi H; Nagahori H; Fukuda T; Lake BG; Cohen SM; Kawamura S
    Toxicol Sci; 2014 Nov; 142(1):137-57. PubMed ID: 25145657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
    Mezei O; Li Y; Mullen E; Ross-Viola JS; Shay NF
    Physiol Genomics; 2006 Jun; 26(1):8-14. PubMed ID: 16507786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR
    Mandala A; Chen WJ; Armstrong A; Malhotra MR; Chavalmane S; McCommis KS; Chen A; Carpenter D; Biswas P; Gnana-Prakasam JP
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G262-G269. PubMed ID: 34287090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic
    Lee YH; Jang HJ; Kim S; Choi SS; Khim KW; Eom HJ; Hyun J; Shin KJ; Chae YC; Kim H; Park J; Park NH; Woo CY; Hong CH; Koh EH; Nam D; Choi JH
    Elife; 2021 Dec; 10():. PubMed ID: 34964438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices.
    Szalowska E; van der Burg B; Man HY; Hendriksen PJ; Peijnenburg AA
    PLoS One; 2014; 9(1):e86795. PubMed ID: 24489787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
    Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
    Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose potentiates L-FABP mediated fibrate induction of PPARα in mouse hepatocytes.
    Petrescu AD; McIntosh AL; Storey SM; Huang H; Martin GG; Landrock D; Kier AB; Schroeder F
    Biochim Biophys Acta; 2013 Aug; 1831(8):1412-25. PubMed ID: 23747828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine and PPARα-agonist fenofibrate are involved in the regulation of Carnitine Acetyltransferase (CrAT) mRNA levels in murine liver cells.
    Kienesberger K; Pordes AG; Völk TG; Hofbauer R
    BMC Genomics; 2014 Jun; 15(1):514. PubMed ID: 24962334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.